Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease

Alimentary Pharmacology and Therapeutics

Volumn 37, Issue 4, 2013, Pages 420-429

  Long, M D ^a   Martin, C ^a   Sandler, R S ^a   Kappelman, M D ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; ADALIMUMAB; AZATHIOPRINE; BALSALAZIDE; CALCINEURIN INHIBITOR; CERTOLIZUMAB PEGOL; CORTICOSTEROID; CYCLOSPORIN; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; OLSALAZINE; SALAZOSULFAPYRIDINE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HERPES ZOSTER; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; ULCERATIVE COLITIS;

6-MERCAPTOPURINE; ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HERPES ZOSTER; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84872676802     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12182     Document Type: Article

References (28)

1. Insinga RP, Itzler RF, Pellissier JM,. Acute/subacute herpes zoster: healthcare resource utilisation and costs in a group of US health plans. Pharmacoeconomics 2007; 25: 155-69.
2. Straus SE, Ostrove JM, Inchauspe G, et al,. NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention. Ann Intern Med 1988; 108: 221-37.
3. Leung J, Harpaz R, Molinari NA, Jumaan A, Zhou F,. Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination. Clin Infect Dis 2011; 52: 332-40.
4. White RR, Lenhart G, Singhal PK, et al,. Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans. Pharmacoeconomics 2009; 27: 781-92.
5. Gupta G, Lautenbach E, Lewis JD,. Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2006; 4: 1483-90.
6. Zhang J, Xie F, Delzell E, et al,. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA 2012; 308: 43-9.
7. Strangfeld A, Listing J, Herzer P, et al,. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA 2009; 301: 737-44.
8. Bongartz T, Orenstein R,. Therapy: the risk of herpes zoster: another cost of anti-TNF therapy? Nat Rev Rheumatol 2009; 5: 361-3.
9. McDonald JR, Zeringue AL, Caplan L, et al,. Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis 2009; 48: 1364-71.
10. Long MD, Herfarth HH, Pipkin CA, Porter CQ, Sandler RS, Kappelman MD,. Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2010; 8: 268-74.
11. Long MD, Porter CQ, Sandler RS, Kappelman MD,. Suboptimal rates of cervical testing among women with inflammatory bowel disease. Clin Gastroenterol Hepatol 2009; 7: 549-53.
12. Long MD, Martin C, Pipkin CA, Herfarth HH, Sandler RS, Kappelman MD,. Risk of melanoma and non-melanoma skin cancer among patients with Inflammatory Bowel Disease. Gastroenterology 2012; 143: 390-9.
13. Stempel DA, Mauskopf J, McLaughlin T, Yazdani C, Stanford RH,. Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast. Respir Med 2001; 95: 227-34.
14. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al,. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007; 5: 1424-9.
15. Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA,. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 2005; 20: 748-53.
16. Klompas M, Kulldorff M, Vilk Y, Bialek SR, Harpaz R,. Herpes zoster and postherpetic neuralgia surveillance using structured electronic data. Mayo Clin Proc 2011; 86: 1146-53.
17. Lund JL, Sturmer T, Porter CQ, Sandler RS, Kappelman MD,. Thiazolidinedione use and ulcerative colitis-related flares: an exploratory analysis of administrative data. Inflamm Bowel Dis 2011; 17: 787-94.
18. Quan H, Sundararajan V, Halfon P, et al,. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005; 43: 1130-9.
19. Deyo RA, Cherkin DC, Ciol MA,. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-9.
20. Hope-Simpson RE,. Postherpetic neuralgia. J R Coll Gen Pract 1975; 25: 571-5.
21. Pergam SA, Forsberg CW, Boeckh MJ, et al,. Herpes zoster incidence in a multicenter cohort of solid organ transplant recipients. Transpl Infect Dis 2011; 13: 15-23.
22. Herrinton LJ, Liu L, Lafata JE, et al,. Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings. Inflamm Bowel Dis 2007; 13: 451-61.
23. Nagasako EM, Johnson RW, Griffin DR, Elpern DJ, Dworkin RH,. Geographic and racial aspects of herpes zoster. J Med Virol 2003; 70 (Suppl 1): S20-3.
24. Flasar MH, Johnson T, Roghmann MC, Cross RK,. Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: a retrospective cohort study. Inflamm Bowel Dis 2008; 14: 13-9.
25. Oxman MN, Levin MJ, Johnson GR, et al,. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352: 2271-84.
26. Hendriksz T, Malouf P, Foy JE,. Vaccines for measles, mumps, rubella, varicella, and herpes zoster: immunization guidelines for adults. J Am Osteopath Assoc 2011; 111: S10-2.
27. Available at: http://www.cdc.gov/vaccines/recs/vacadmin/downloads/ contraindicationsguide-508.pdf. Accessed December 4, 2012.
28. Zhang J, Delzell E, Xie F, et al,. The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study. Arthritis Res Ther 2011; 13: R174.